Tag Archives: ghk-cu
GHK-Cu: 50 Years of Research, None on Injection
GHK-Cu has decades of human trials as a topical serum and none as an injection, NPR reports, with an FDA panel reviewing the injectable in February.
BPC-157 in a Harvard Pain Review: 7 Peptides, Little Data
BPC-157, TB-500 and GHK-Cu appear in a 2026 Harvard pain medicine review. Its closing line is that most remain unapproved and human evidence is limited.
GHK-Cu: 18 of 20 Studies in a New Review Are Preclinical
GHK-Cu: a 2026 systematic review pooled 20 studies on the copper peptide. Only two were randomised trials, and the authors say so plainly.
GHK-Cu Skin Research: Two New 2026 Papers, and Why Their Design Differs
Two GHK-Cu papers published in 2026 report anti-inflammatory and skin findings. One comes from a cosmetics company's own R&D centre, the other from a university lab, and neither tested the peptide on its own.